Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). - Test2 - elhamkhani - TriplyDB

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

http://www.wikidata.org/entity/Q33711444

about

Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.Effects of transcutaneous electrical nerve stimulation on chemotherapy-induced peripheral neuropathy symptoms (CIPN): a preliminary case-control study.Chemotherapy-induced neuropathy: Central resolution of a peripherally perceived problem?Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity.

P2860

Q30491771-0C5A95F1-CF30-41CB-ACBB-CBA003705A90 Q33680116-F11DA6D6-EE31-4182-B1A0-6CD5954DCCC1 Q48167422-69C29363-555B-4D31-854A-4BF73612415F Q52648842-584C512E-206D-408C-BC5A-340C5F95754D

P2860

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

http://www.wikidata.org/entity/Q33711444

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@ast

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@en

type

label

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@ast

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@en

prefLabel

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@ast

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@en

P1433

Q33711444-71514929-57F3-449B-BB51-023019D437FF

P1476

Q33711444-FAFF4040-7AE1-48C1-9D16-D508CD226324

P2093

Q33711444-1627D6D8-A2A3-4959-A91E-FD2DCFE76D2F

Q33711444-2E61694F-C003-4222-83EF-8071A415AD70

Q33711444-48DCFA87-5151-4369-BA87-F41229CF48C8

Q33711444-510E5655-9603-4DDA-A96C-4E7E43E8173F

Q33711444-79F93597-63F5-44E7-8701-BB3C43FFA07C

Q33711444-8C128224-57DA-4BED-861E-C3EDCE383D70

Q33711444-B49498D9-1AD2-4A0F-AC20-B02C4F4F3744

Q33711444-C7E66A7B-DD5E-4C48-A15D-8B48F984E6EF

Q33711444-C85D25E3-DC6B-4356-8771-8CD66ECD8334

Q33711444-D7ADF3E2-B6E9-419F-900F-85D6A8535A5D

P2860

Q33711444-053FF5C2-FB1A-41A6-8F4C-19817D45DD3C

Q33711444-1E17C316-F2C9-41A5-A3AB-F3B1840C4F03

Q33711444-25F5E795-F742-46BE-9E6A-CE17C993A033

Q33711444-279CEEBD-6A88-4DC2-8E84-F981255AB925

Q33711444-2D00E556-2DC8-4CB7-9D29-5854F492347C

Q33711444-3A9EAEDB-A810-4062-8E1F-1BBB1A452CB5

Q33711444-3B6E3CA6-5735-40FC-94A0-AB4545269F19

Q33711444-45053EE4-A4E7-450A-877C-F5D1FCD6788D

Q33711444-4ABA01D0-BC5D-4EE3-919E-A2C0B6A355AC

Q33711444-4CD8A882-C6A1-48BE-BA86-9C78679A0F3B

P2888

Q33711444-D2BC39A3-F88E-43EA-B20B-1CBD49985C94

P304

Q33711444-46100CE0-F6F4-47F7-95CC-9BE3D8B7275E

P31

Q33711444-57D9136B-B412-40F8-9E51-4A95CF125FCE

P356

Q33711444-45387D6F-1CB3-47FA-A387-F10903F27BF2

P433

Q33711444-359174AF-220B-4FCA-9B4E-F63693F1D25E

P478

Q33711444-C1E06B36-585C-4AD0-904F-F21BC9F4EED3

P50

Q33711444-39BB916B-143B-401B-B7C0-3636B3B0BE52

Q33711444-95BCED54-2C51-4FFE-8AC6-F7053ADA8D93

Q33711444-962346E0-A158-4B53-9C74-D9BEC167EC66

P577

Q33711444-997A79E8-9E6A-4380-BAD4-2B83485DCB2B

P698

Q33711444-12683462-049C-4D98-9119-8E89918A40DC

P932

Q33711444-E7DB63C0-6E1E-46E1-B6A8-85C77B00B36A

P356

S00520-016-3373-1

P1433

Supportive Care in Cancer

P1476

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

@en

P2093

Andreas S Beutler

http://www.w3.org/2001/XMLSchema#string

Axel Grothey

http://www.w3.org/2001/XMLSchema#string

Charles L Loprinzi

http://www.w3.org/2001/XMLSchema#string

Deirdre R Pachman

http://www.w3.org/2001/XMLSchema#string

Drew Seisler

http://www.w3.org/2001/XMLSchema#string

Ellen M Lavoie Smith

http://www.w3.org/2001/XMLSchema#string

Jacqueline M Lafky

http://www.w3.org/2001/XMLSchema#string

Kathryn J Ruddy

http://www.w3.org/2001/XMLSchema#string

Lauren E Ta

http://www.w3.org/2001/XMLSchema#string

Nina D Wagner-Johnston

http://www.w3.org/2001/XMLSchema#string

P2860

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Predicting acute and persistent neuropathy associated with oxaliplatin.

Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity.

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01.

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current.

An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).

P2888

s00520-016-3373-1

P304

5059-5068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-016-3373-1

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Patrick M. Dougherty

Nathan P. Staff

Guido Cavaletti

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27534963

http://www.w3.org/2001/XMLSchema#string

P932

5439148

http://www.w3.org/2001/XMLSchema#string